- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Ligand id: 6826
View more information in the IUPHAR Pharmacology Education Project: levetiracetam
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|Approved drug?||Yes (FDA (1999), EMA (2000))|
|International Nonproprietary Names|
|Keppra® | Spritam® | UCB L059 | UCB-L 059|
|In addition to being assigned an INN in its own right, levetiracetam is the biologically active enantiomer of racemic formulation etiracetam, also assigned an INN.
Levetiracetam is the active compound in Spritam®, the first 3D printed pill to be approved by the US FDA (in August 2015).
|CAS Registry No.||102767-28-2|
|GtoPdb PubChem SID||178103432|
|Search Google for chemical match using the InChIKey||HPHUVLMMVZITSG-LURJTMIESA-N|
|Search Google for chemicals with the same backbone||HPHUVLMMVZITSG|
|Search PubMed clinical trials||levetiracetam|
|Search PubMed titles||levetiracetam|
|Search PubMed titles/abstracts||levetiracetam|
|Search UniChem for chemical match using the InChIKey||HPHUVLMMVZITSG-LURJTMIESA-N|
|Search UniChem for chemicals with the same backbone||HPHUVLMMVZITSG|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Cat. No. 2839